We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

72 hedge funds and large institutions have $92.9M invested in Minerva Neurosciences in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $755K | Put options by funds: $337K

33% more capital invested

Capital invested by funds: $70M → $92.9M (+$22.9M)

13% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 23

0.58% more ownership

Funds ownership: 8.61% → 9.19% (+0.58%)

5% less funds holding

Funds holding: 76 → 72 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
72
Holders Change
-4
Holders Change %
-5.26%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
26
Reduced
23
Closed
9
Calls
$755K
Puts
$337K
Net Calls
+$418K
Net Calls Change
+$383K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$1.55M
2
Morgan Stanley
Morgan Stanley
New York
+$1.39M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.37M
4
AC
Armistice Capital
New York
+$1.29M
5
Los Angeles Capital Management
Los Angeles Capital Management
California
+$584K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$772K
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$348K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$195K
4
AFM
Anson Funds Management
Texas
-$163K
5
FM
Frazier Management
Washington
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$28.1M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$12.9M +$539K +21,574 +4%
BlackRock
3
BlackRock
New York
$6.81M +$382K +15,272 +6%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$5.09M +$99.2K +3,971 +2%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$3.18M -$143K -5,704 -4%
Goldman Sachs
6
Goldman Sachs
New York
$2.79M -$110K -4,405 -4%
Morgan Stanley
7
Morgan Stanley
New York
$2.71M +$1.39M +55,731 +92%
AC
8
Armistice Capital
New York
$2.66M +$1.29M +51,500 +82%
Assenagon Asset Management
9
Assenagon Asset Management
Luxembourg
$2.41M +$1.37M +54,778 +113%
Jacobs Levy Equity Management
10
Jacobs Levy Equity Management
New Jersey
$2.21M +$524K +20,965 +28%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.03M +$239K +9,572 +12%
Wells Fargo
12
Wells Fargo
California
$1.84M +$1.55M +61,965 +371%
Millennium Management
13
Millennium Management
New York
$1.67M +$516K +20,632 +41%
State Street
14
State Street
Massachusetts
$1.66M -$82K -3,281 -4%
N
15
Nuveen
North Carolina
$1.65M -$10.1K -406 -3%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$1.58M -$99.9K -4,000 -6%
Renaissance Technologies
17
Renaissance Technologies
New York
$1.28M -$772K -30,893 -36%
Two Sigma Investments
18
Two Sigma Investments
New York
$1.28M +$23.3K +931 +2%
Fidelity Investments
19
Fidelity Investments
Massachusetts
$1.15M -$3.12K -125 -0.3%
Northern Trust
20
Northern Trust
Illinois
$1.08M -$69.4K -2,776 -6%
SEI Investments
21
SEI Investments
Pennsylvania
$888K +$108K +4,333 +13%
BCM
22
Bridgeway Capital Management
Texas
$683K -$17.2K -688 -2%
CAM
23
Cormorant Asset Management
Massachusetts
$584K – – –
Los Angeles Capital Management
24
Los Angeles Capital Management
California
$546K +$584K +23,392 New
JP Morgan Chase
25
JP Morgan Chase
New York
$541K +$7.2K +288 +1%
1
2 3 4

NERV Hedge Fund Activity: Q1 2021 in Review

72 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2021, worth a combined $92.9M — up 33% from $70M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NERV and 5 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 26 added.

The largest buyer was Wells Fargo, adding an estimated $1.55M. The largest seller was Renaissance Technologies, cutting an estimated $772K.

  • 72 institutional investors held Minerva Neurosciences (NERV) as of Q1 2021, down from 76 in Q4 2020.
  • Funds reported $92.9M of Minerva Neurosciences stock for Q1 2021, up 33% quarter-over-quarter.
  • 5 funds opened new Minerva Neurosciences positions in Q1 2021 and 9 closed out, a net change of -4 holders.
  • The largest Minerva Neurosciences buyer in Q1 2021 was Wells Fargo, an estimated $1.55M added.
  • The largest Minerva Neurosciences seller in Q1 2021 was Renaissance Technologies, an estimated $772K sold.

Based on aggregated 13F filings for Q1 2021.